Panomics

Less than a year after Affymetrix bought eBioscience, the array vendor is finding ways to combine its background in microarray and branched-DNA genotyping and expression with eBio's flow cytometry reagents and multiplex immunoassay portfolios.

This article was originally posted on Feb. 1

Affymetrix this week reported a slight uptick in its second-quarter revenues, which increased 3 percent to $66.4 million from $64.7 million in the year-ago period, beating the average analyst estimate of $65.6 million.

This story was originally posted on Nov. 3
By Justin Petrone

NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.

IP Roundup

Premium

Korea Electro Technology Research Institute of Changwon, Korea, has received US Patent No.

Acknowledging the challenges the firm faces and admitting it has been "slow to respond to technology changes" in the market, Frank Witney said the firm still has some opportunities to restore growth — if it positions its products correctly.

Movers & Shakers

Premium

Brandon Ruotolo, Frank Witney, Kevin King, Ronald DePinho, John Mendelsohn, Lynda Chin

IP Roundup

Premium

Northwestern University, Affymetrix, Centre National de la Recherche Scientifique

INSERM and Affymetrix win US patents.

Pages

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.